aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 tha...
Q1 2026
May 6, 2026
FY 2025
Mar 5, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 7, 2025